⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL402098 | 0.72 | — | — | |
| SCHEMBL55741 | 0.59 | — | — | |
| SCHEMBL503156 | 0.57 | — | — | |
| SCHEMBL26690 | 0.56 | — | — | |
| SCHEMBL165797 | 0.56 | — | — | |
| SCHEMBL3698345 | 0.54 | — | — | |
| SCHEMBL13077013 | 0.54 | — | — | |
| SCHEMBL11680869 | 0.53 | — | — | |
| SCHEMBL3705843 | 0.53 | — | — | |
| SCHEMBL26728608 | 0.53 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1467734-A1 | COTHERAPY WITH AN OXAZOLIDINONE AND A VITAMIN B | PHARMACIA & UPJOHN COMPANY (US) | 2004-10-20 | — | — | EP | disclosed |
| US-20030171331-A1 | The present invention describes a novel cotherapy of oxazolidinones and at least one vitamin selected from vitamin B2, vitamin B6, vitamin B12 and folic acid. | PHARMACIA & UPJOHN COMPANY | 2003-09-11 | — | — | US | disclosed |
| WO-2003063862-A1 | COTHERAPY WITH AN OXAZOLIDINONE AND A VITAMIN B | PHARMACIA & UPJOHN COMPANY (US) | 2003-08-07 | — | — | WO | disclosed |